Trial intelligence / Profile preview

Sex Differences in Neurobehavioral Response to Acute THC in Adults With Cannabis Use Disorder

NCT07225777Phase 2Terminated

Sponsor
Medical University of South Carolina
Start
Apr 2026
Primary completion
Aug 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of dronabinol in cannabis use disorder (CUD), sponsored by Medical University of South Carolina. Started Apr 2026; status: terminated.

02

Drugs

dronabinol
03

Conditions

cannabis use disorder (CUD)

Beyond the preview

Go deeper on NCT07225777.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07225777.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call